Cite
MLA Citation
A. Kavanaugh et al.. “FRI0345 HEAD-TO-HEAD STUDY EVALUATING THE COMBINED ACR50/PASI100 TREATMENT RESPONSE OF IXEKIZUMAB VERSUS ADALIMUMAB: INDIVIDUAL PATIENT DATA FROM A RANDOMIZED, OPEN-LABEL STUDY IN BIOLOGIC-NAÏVE PATIENTS WITH PSORIATIC ARTHRITIS THROUGH WEEK 52.” Annals of the rheumatic diseases, vol. 79, n.d., p. 767. http://access.bl.uk/ark:/81055/vdc_100144716836.0x00004c